ConductScience.org, home

Paper2597774

Polycythemia vera. A clinical study of 141 patients.

Anger B and 3 others. Blut, 1989. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Polycythemia vera. A clinical study of 141 patients. Papers, record 2597774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2597774

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Polycythemia vera. A clinical study of 141 patients.
PubMed
Journal
Blut
PubMed
Year
1989
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.84
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anger BB
2Haug UU
3Seidler RR
4Heimpel HH

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Polycythemia VeraMajor topic
Adult
Aged
Bone Marrow
Erythrocyte Count
Female
Humans
Male
Middle Aged
Primary Myelofibrosis
Prognosis
Retrospective Studies
Survival Analysis
Thromboembolism

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16496458Treatment of polycythemia vera with hydroxyurea.Am J Hematol1984https://conductscience.org/library/papers/6496458PubMed
214339771POLYCYTHEMIA VERA AND LEUKEMIA--THE ROLE OF RADIATION TREATMENT. A STUDY OF 1222 PATIENTS.Medicine (Baltimore)1965https://conductscience.org/library/papers/14339771PubMed
35683536A study of hematological complications occurring in patients with polycythemia vera treated with 32-P (based on a series of 296 patients).Blood1968https://conductscience.org/library/papers/5683536PubMed
54084455Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre.Br J Haematol1985https://conductscience.org/library/papers/4084455PubMed
6967201Polycythemia vera: stem-cell and probable clonal origin of the disease.N Engl J Med1976https://conductscience.org/library/papers/967201PubMed
73401588A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course.Blood1988https://conductscience.org/library/papers/3401588PubMed
83704665Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.Semin Hematol1986https://conductscience.org/library/papers/3704665PubMed
93749925Long-term management of polycythemia vera with hydroxyurea: a progress report.Semin Hematol1986https://conductscience.org/library/papers/3749925PubMed
106722763Chromosome studies in polycythemia vera patients.Cancer Genet Cytogenet1984https://conductscience.org/library/papers/6722763PubMed
1118552568Chronic cyanosis, with polycythaemia and enlarged spleen: a new clinical entity. 1903.Am J Med Sci2008https://conductscience.org/library/papers/18552568PubMed
123704666Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.Semin Hematol1986https://conductscience.org/library/papers/3704666PubMed
136943932Karyotypic patterns and their clinical significance in polycythemia vera.Am J Hematol1981https://conductscience.org/library/papers/6943932PubMed
143749928Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.Semin Hematol1986https://conductscience.org/library/papers/3749928PubMed
15905766Polycythaemia vera terminating in acute leukaemia. A clinical, cytogenetic and morphologic study in 8 patients treated with alkylating agents.Scand J Haematol1977https://conductscience.org/library/papers/905766PubMed
166082224Polycythaemia vera and myelofibrosis.Scand J Haematol1967https://conductscience.org/library/papers/6082224PubMed
173965109The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis.Cancer1985https://conductscience.org/library/papers/3965109PubMed
1814212605POLYCYTHAEMIA VERA: CLINICAL STUDIES ON A SERIES OF 127 PATIENTS MANAGED WITHOUT RADIATION THERAPY.Q J Med1964https://conductscience.org/library/papers/14212605PubMed
191105793Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.Semin Hematol1975https://conductscience.org/library/papers/1105793PubMed
203327560Rheology of the absolute polycythaemias.Baillieres Clin Haematol1987https://conductscience.org/library/papers/3327560PubMed
214833938Postpolycythemia myeloid metaplasia.Arch Intern Med1974https://conductscience.org/library/papers/4833938PubMed

See all 34 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
36589600Use of nailfold video capillaroscopy in polycythemia vera.Arch Rheumatol2022https://conductscience.org/library/papers/36589600PubMed
27479815A novel role for nuclear factor-erythroid 2 in erythroid maturation by modulation of mitochondrial autophagy.Haematologica2016https://conductscience.org/library/papers/27479815PubMed
23993426Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome.Leuk Res2013https://conductscience.org/library/papers/23993426PubMed
22569900The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.J Thromb Thrombolysis2012https://conductscience.org/library/papers/22569900PubMed
19633771Congenital and acquired polycythemias.Dtsch Arztebl Int2008https://conductscience.org/library/papers/19633771PubMed
18791061Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/18791061PubMed
1912029Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.Ann Hematol1991https://conductscience.org/library/papers/1912029PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2597774

GET https://conductscience.org/api/papers/v1/2597774/references?page=2